The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom
- 150 Downloads
Delayed ischaemic neurological deficit (DID) following subarachnoid haemorrhage from aneurysm rupture (aSAH) is a serious complication and a major cause of mortality and morbidity. No empirical estimates of resource use and costs of patients with delayed ischaemic deficit compared to those without have been reported to date.
A detailed cost analysis of the UK National Health Service health care costs of DID was performed using resource use data from the International Subarachnoid Aneurysm Trial (ISAT) over the 24 months following haemorrhage. Resource use categories included direct health care and employment-related costs. A prognostic model of baseline predictors of DID and overall total health care costs was also constructed.
Mean (standard deviation) total health care costs at 24 months follow-up were estimated to be £ 28175 (£ 26773) in the DID group and £ 18805 (£ 17287) in the no DID group, a significant difference (95 % confidence interval) of £ 9370 (£ 6880 to £ 12516). This cost difference was driven by statistically significant differences on imaging and investigations, longer length of stay and higher cost of complications and adverse events experienced by patients with DID. Patients with DID also spent on average 62 days less in paid employment than patients without this complication. The prognostic model found CT Fisher grading, WFNS grade, aneurysm location and time from aSAH to intervention statistically significant baseline predictors of delayed ischaemic deficit.
Patients who developed DID incurred substantially higher costs and a significantly slower resumption of employment than patients without at 24 months follow-up after aSAH.
Key wordssubarachnoid haemorrhage delayed ischaemic neurological deficit costs prognostic model vasospasm
- 1.Solenski NJ, Haley EC Jr, Kassell NF,Kongable G, Germanson T, TruskowskiL, Torner JC (1995) Medical complicationsof aneurysmal subarachnoidhemorrhage: a report of the multicenter,cooperative aneurysm study.Participants of the Multicenter CooperativeAneurysm Study. Crit Care Med23(6):1007–1017PubMedCrossRefGoogle Scholar
- 3.Dorsch NWC, King MT (1994) A reviewof cerebral vasospasm in aneurysmalsubarachnoid haemorrhagePart I: Incidence and effects. J ClinNeurosci 1(1):19–26Google Scholar
- 5.Molyneux A, Kerr R, Stratton I,Sander cock P, Clarke M, Shrimpton J,Holman R (2002) International SubarachnoidAneurysm Trial (ISAT) ofneurosurgical clipping versus endovascularcoiling in 2143 patients with rupturedintracranial aneurysms: a randomisedtrial. Lancet360(9342):1267–1274PubMedCrossRefGoogle Scholar
- 7.Molyneux AJ, Kerr RSC, Yu LM, ClarkeM, Sneade M, Yarnold JA, Sandercock P(2005) International subarachnoid aneurysmtrial (ISAT) of neurosurgicalclipping versus endovascular coiling in2143 patients with ruptured intracranialaneurysms: a randomised comparisonof effects on survival, dependency,seizures, rebleeding, subgroups,and aneurysm occlusion. Lancet 366(9488):809–817PubMedCrossRefGoogle Scholar
- 8.Department of Health (2006) NHSFinance Manual. Financial Matters;Newsletter. Department of Health;Available at: URL: http://www.info.doh.gov.uk/doh/finman.nsf/Newsletters?OpenViewGoogle Scholar
- 11.Suzuki J, Komatsu S, Sato T, Sakurai Y(1980) Correlation between CT findingsand subsequent development ofcerebral infarction due to vasospasmin subarachnoid haemorrhage. ActaNeurochir 55(1–2):63–70Google Scholar